Axie Cell High MTV - Is Age a Determinant of CAR T Cell Eligibility?

I think we're starting to get into that landscape in the clinical trials where we have enough data, we've enriched the population enough because I think you and I can agree Dr. Love that there's still a significant amount of area above the curve in the event-free survival. We can try to do better to cure more patients in second-line larsal lymphoma especially in this heavily chemo refractory patient population that's just their disease laughed at our chop. With Axie cell you had a better chance of getting into a CR with CAR T cell therapy compared to chemo immunotherapy and regardless of age your probability of living longer was higher if you were shunted down that